Neurotech International Limited

CHIA:NTI Stock Report

Market Cap: AU$63.1m

Neurotech International Valuation

Is NTI undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NTI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: NTI (A$0.06) is trading above our estimate of fair value (A$0.04)

Significantly Below Fair Value: NTI is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NTI?

Key metric: As NTI is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for NTI. This is calculated by dividing NTI's market cap by their current revenue.
What is NTI's PS Ratio?
PS Ratio19.9x
SalesAU$3.18m
Market CapAU$63.11m

Price to Sales Ratio vs Peers

How does NTI's PS Ratio compare to its peers?

The above table shows the PS ratio for NTI vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3.1x
CVB CurveBeam AI
6.4x45.9%AU$41.4m
MX1 Micro-X
2.6x38.2%AU$39.0m
CDX CardieX
2.7x54.8%AU$35.3m
SOM SomnoMed
0.6x9.0%AU$60.5m
NTI Neurotech International
19.9x44.7%AU$63.1m

Price-To-Sales vs Peers: NTI is expensive based on its Price-To-Sales Ratio (19.9x) compared to the peer average (3.1x).

Price to Sales Ratio vs Industry

How does NTI's PS Ratio compare vs other companies in the AU Medical Equipment Industry?

8 CompaniesPrice / SalesEstimated GrowthMarket Cap
SDI SDI
1.1x5.4%US$81.52m
SOM SomnoMed
0.6x9.0%US$39.52m
CMP Compumedics
1xn/aUS$36.61m
NXS Next Science
1.1x30.6%US$26.71m
NTI 19.9xIndustry Avg. 3.2xNo. of Companies11PS0612182430+
8 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: NTI is expensive based on its Price-To-Sales Ratio (19.9x) compared to the Australian Medical Equipment industry average (3.1x).

Price to Sales Ratio vs Fair Ratio

What is NTI's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NTI PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio19.9x
Fair PS Ratio23.1x

Price-To-Sales vs Fair Ratio: NTI is good value based on its Price-To-Sales Ratio (19.9x) compared to the estimated Fair Price-To-Sales Ratio (23.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

SDI

AU$124.8m

Engages in the research and development, manufacture, and marketing of dental restorative materials, whitening systems, and other dental materials in Australia, Europe, the United States, and Brazil.

SDI

AU$1.03

7D

0.5%

1Y

24.1%

Doctor Care Anywhere Group

AU$25.3m

Provides digital healthcare and development services in the United Kingdom, Australia, and the Republic of Ireland.

DOC

AU$0.068

7D

1.5%

1Y

36.0%

SDI

AU$124.8m

Engages in the research and development, manufacture, and marketing of dental restorative materials, whitening systems, and other dental materials in Australia, Europe, the United States, and Brazil.

SDI

AU$1.08

7D

5.4%

1Y

29.5%